Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD3 is a cell surface protein complex critical for T cell biology and immune signaling. It is composed of four subunits—CD3γ, CD3δ, CD3ε, and CD3ζ—arranged in dimers that associate noncovalently with the T cell receptor (TCR). The CD3 complex is essential for antigen recognition and transduction of activation signals following TCR stimulation via its immunoreceptor tyrosine-based activation motifs (ITAMs). CD3 is both a defining marker for T cell identification and an important target for monoclonal antibody therapeutics in cancer, transplant rejection, and autoimmune disorders. Safety concerns with CD3 targeting therapies include cytokine release syndrome and profound immunosuppression
Antibody-mediated depletion of T cells (immunosuppression) Modulation of T cell activation Induction of T cell anergy or apoptosis Immunomodulation via ITAM phosphorylation and downstream signaling pathways
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD3 protein complex (CD3).